Lyrica (Pregabalin) - New Gabapentinoid with Wide Clinical Application
Key Data:
Drug (Brand/Generic)
Lyrica / pregabalin
Company/Licensee
Pfizer
Therapy Class
Antiepileptic
Product Description
GABA analogue
Current Indication
Treatment of neuropathic pain, adjunctive therapy in epilepsy and treatment of generalised anxiety disorder
Market Sector
CNS, pain control
Development Status
Approved for neuropathic pain in Europe and the US and additionally for partial seizures in Europe and the US
